Rifampicin (600 mg én gang dagligt) nedsætter Cmax (maksimal plasmakoncentration) og AUCτ (arealet under plasmakoncentrationstidskurven inden for et dosisinterval) af voriconazol med henholdsvis 93% og 96%.
Rifampicin (600 mg once daily) decreased the Cmax (maximum plasma concentration) and AUCτ (area under the plasma concentration time curve within a dose interval) of voriconazole by 93% and 96%, respectively.